165 related articles for article (PubMed ID: 35348268)
1. NCAPD2 promotes breast cancer progression through E2F1 transcriptional regulation of CDK1.
He J; Gao R; Yang J; Li F; Fu Y; Cui J; Liu X; Huang K; Guo Q; Zhou Z; Wei W
Cancer Sci; 2023 Mar; 114(3):896-907. PubMed ID: 35348268
[TBL] [Abstract][Full Text] [Related]
2. Non-SMC condensin I complex subunit D2 and non-SMC condensin II complex subunit D3 induces inflammation
Yuan CW; Sun XL; Qiao LC; Xu HX; Zhu P; Chen HJ; Yang BL
World J Gastroenterol; 2019 Dec; 25(47):6813-6822. PubMed ID: 31885422
[TBL] [Abstract][Full Text] [Related]
3. Non-SMC Condensin I Complex Subunit D2 Is a Prognostic Factor in Triple-Negative Breast Cancer for the Ability to Promote Cell Cycle and Enhance Invasion.
Zhang Y; Liu F; Zhang C; Ren M; Kuang M; Xiao T; Di X; Feng L; Fu L; Cheng S
Am J Pathol; 2020 Jan; 190(1):37-47. PubMed ID: 31610177
[TBL] [Abstract][Full Text] [Related]
4. NCAPD2 inhibits autophagy by regulating Ca
Jing Z; He X; Jia Z; Sa Y; Yang B; Liu P
Cancer Lett; 2021 Nov; 520():26-37. PubMed ID: 34229059
[TBL] [Abstract][Full Text] [Related]
5. GSG2 facilitates the progression of human breast cancer through MDM2-mediated ubiquitination of E2F1.
Tang Y; Dai G; Yang Y; Liu H
J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
[TBL] [Abstract][Full Text] [Related]
6. Non-SMC condensin I complex subunit D2 (NCAPD2) reveals its prognostic and immunologic features in human cancers.
Dong X; Liu T; Li Z; Zhai Y
Aging (Albany NY); 2023 Jul; 15(14):7237-7257. PubMed ID: 37498296
[TBL] [Abstract][Full Text] [Related]
7. NCAPD2 is a novel marker for the poor prognosis of lung adenocarcinoma and is associated with immune infiltration and tumor mutational burden.
Li Z; Zheng Y; Wu Z; Zhuo T; Zhu Y; Dai L; Wang Y; Chen M
Medicine (Baltimore); 2023 Jan; 102(3):e32686. PubMed ID: 36701707
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of E2F1/CDK1 pathway attenuates neuronal apoptosis in vitro and confers neuroprotection after spinal cord injury in vivo.
Wu J; Kharebava G; Piao C; Stoica BA; Dinizo M; Sabirzhanov B; Hanscom M; Guanciale K; Faden AI
PLoS One; 2012; 7(7):e42129. PubMed ID: 22848730
[TBL] [Abstract][Full Text] [Related]
9. Regulator of chromatin condensation 1 abrogates the G1 cell cycle checkpoint via Cdk1 in human papillomavirus E7-expressing epithelium and cervical cancer cells.
Qiao L; Zheng J; Tian Y; Zhang Q; Wang X; Chen JJ; Zhang W
Cell Death Dis; 2018 May; 9(6):583. PubMed ID: 29789527
[TBL] [Abstract][Full Text] [Related]
10. Rewiring E2F1 with classical NHEJ via APLF suppression promotes bladder cancer invasiveness.
Richter C; Marquardt S; Li F; Spitschak A; Murr N; Edelhäuser BAH; Iliakis G; Pützer BM; Logotheti S
J Exp Clin Cancer Res; 2019 Jul; 38(1):292. PubMed ID: 31287003
[TBL] [Abstract][Full Text] [Related]
11. miR-1258 Regulates Cell Proliferation and Cell Cycle to Inhibit the Progression of Breast Cancer by Targeting E2F1.
Zhao X
Biomed Res Int; 2020; 2020():1480819. PubMed ID: 32733928
[TBL] [Abstract][Full Text] [Related]
12. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
[TBL] [Abstract][Full Text] [Related]
13. E2F1-initiated transcription of PRSS22 promotes breast cancer metastasis by cleaving ANXA1 and activating FPR2/ERK signaling pathway.
Song L; Li H; Ma RR; Liu S; Zhang GH; Guo XY; Zhao RN; Wu XJ; Zhang K; Gao P
Cell Death Dis; 2022 Nov; 13(11):982. PubMed ID: 36414640
[TBL] [Abstract][Full Text] [Related]
14. NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway.
Li B; Xiao Q; Shan L; Song Y
Cell Cycle; 2022 Feb; 21(4):427-438. PubMed ID: 34974790
[TBL] [Abstract][Full Text] [Related]
15. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
Pandolfi S; Montagnani V; Lapucci A; Stecca B
Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
[TBL] [Abstract][Full Text] [Related]
16. Linkage of E2F1 transcriptional network and cell proliferation with respiratory chain activity in breast cancer cells.
Mori K; Uchida T; Fukumura M; Tamiya S; Higurashi M; Sakai H; Ishikawa F; Shibanuma M
Cancer Sci; 2016 Jul; 107(7):963-71. PubMed ID: 27094710
[TBL] [Abstract][Full Text] [Related]
17. p63α protein up-regulates heat shock protein 70 expression via E2F1 transcription factor 1, promoting Wasf3/Wave3/MMP9 signaling and bladder cancer invasion.
Jin H; Xie Q; Guo X; Xu J; Wang A; Li J; Zhu J; Wu XR; Huang H; Huang C
J Biol Chem; 2017 Sep; 292(38):15952-15963. PubMed ID: 28794159
[TBL] [Abstract][Full Text] [Related]
18. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-361-3p promotes human breast cancer cell viability by inhibiting the E2F1/P73 signalling pathway.
Hua B; Li Y; Yang X; Niu X; Zhao Y; Zhu X
Biomed Pharmacother; 2020 May; 125():109994. PubMed ID: 32092817
[TBL] [Abstract][Full Text] [Related]
20. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
